Pharmaceutical Technology

FEBRUARY 14, 2023

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. Bristol-Myers Squibb is the leading patent filer in nanoparticles for drug delivery.

Drug Delivery 147

Drug Delivery Drugs Drug Delivery Systems FDA Approval 147

XTalks

MAY 2, 2024

In 2023, the US Food and Drug Administration (FDA) approved a record-breaking 61 drugs, the most in history. Since January, the FDA has already signed off on more than a dozen novel drugs. The agency is reviewing applications for several highly anticipated drugs for approval in 2024. At the J.P. billion and $3.6

Drugs 52

Drugs FDA Approval Sales Vaccination 52

pharmaphorum

JUNE 8, 2021

Dementia specialist Prof Robert Howard of University College London (UCL) was also damning in his assessment of the decision, saying that the FDA has “sidestepped available clinical trial outcomes data that indicate the drug probably doesn’t work.” Accelerated approval is probably a reasonable middle ground here.

Drugs 98

Drugs Marketing FDA Approval Trials 98

XTalks

FEBRUARY 5, 2024

Arexvy and Abrysvo , the world’s first vaccines against RSV, were approved in 2023 and have been head-to-head competitors since their US Food and Drug Administration (FDA) approvals for individuals 60 years of age and older, which were granted just weeks apart. At the J.P. billion in 2022 to $9 billion by 2029.

Vaccination 59

Vaccination Vaccine Marketing Sales 59

Pharmaceutical Technology

FEBRUARY 1, 2023

As paediatric hospital wings are flooded with an unprecedented number of respiratory syncytial virus (RSV) cases , healthcare workers have been overwhelmed by an unusually early peak of the RSV season. GlobalData is the parent company of Pharmaceutical Technology. According to the Centers for Disease Control and Prevention (CDC) , 45.8

Vaccination 162

Vaccination Vaccine Antibody FDA Approval 162

Pharmaceutical Technology

OCTOBER 26, 2022

The biotherapeutics market is rapidly growing, with 2021 seeing the highest-ever cell and gene therapy approval number. Early gene therapy methods were proposed in the 1970s, and the first approved gene therapy clinical research in the US began in 1990. Gene and cell therapies are revolutionising the way healthcare is delivered.

Gene Therapy 130

Gene Therapy Gene Marketing Manufacturing 130

Pharmaceutical Technology

AUGUST 8, 2022

Yet, despite the landmark FDA approval, digital pills have not exploded in pharma. There’s no dearth of interest, however, in applying digital solutions to healthcare. The digital pill, now marketed by Otsuka Pharmaceuticals, is forecasted to make $27 million in sales in 2022, as per GlobalData.

FDA Approval 305

FDA Approval Medicine Trials Drugs 305

Pharmaceutical Technology

JANUARY 27, 2023

In 2019, Cablivi became the first FDA-approved , nanobody-based medicine for acquired thrombotic thrombocytopenic purpura (aTTP), an ultra-orphan condition that causes blood clots in small blood vessels around the body. Hlávka says healthcare providers often ask, “Should we only pay for some of the patients?

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

Pharmaceutical Technology

MAY 24, 2023

Innoviva has snagged a win for its bacterial pneumonia drug Xacduro (durlobactam sodium + sulbactam) with a US Food and Drug Administration FDA approval for use in patients of ages 18 or older. The FDA approval stemmed from results from Entasis’ Phase III Attack trial (NCT03894046).

FDA Approval 130

FDA Approval Bacteria Contamination Pharma Companies 130

Pharmaceutical Technology

MAY 3, 2023

“According to the FDA, the introduction of generic medicines offers patients “same as brand” drugs at 39% lower-than-average price,” says Surbhi Gupta, an industry analyst within Frost & Sullivan’s healthcare and life sciences practice area. Evaluate the effects of COVID-19 on the sector.

Generic Drugs 246

Generic Drugs Branding Drugs Production 246

Pharmaceutical Technology

MARCH 21, 2023

In early February, the FDA approved Regeneron Pharmaceuticals’ Eylea (aflibercept) injection to treat the rare disorder retinopathy of prematurity (ROP) in preterm infants. Regulatory decisions by the FDA and EMA for select therapies from late January to late February and the CMOs contracted to manufacture the therapies.

Manufacturing 147

Manufacturing Drugs Packaging Packaging 147

Pharmaceutical Technology

JANUARY 15, 2023

Using the manufacturing contract-related data collated from PharmSource reports, and news from the GlobalData Pharma Intelligence Center, Pharmaceutical Technology has collated some of the key regulatory events from late November to late December that will likely impact manufacturing volumes, and stakeholders that will likely be affected.

Manufacturing 130

Manufacturing Packaging Packaging Contract Manufacturing 130

Pharmaceutical Technology

FEBRUARY 6, 2023

According to GlobalData, there are 25 marketed drugs for IPF available in North America. GlobalData is the parent company of Pharmaceutical Technology. According to GlobalData, 29 drugs are currently marketed for managing the complications of PSC, but none can reverse liver damage associated with PSC.

Marketing 147

Marketing Clinical Trials Clinical Trials Trials 147

Pharmaceutical Technology

MARCH 6, 2023

Currently, most drugs being investigated for their healthy aging or anti-aging properties are being repurposed from readily accessible FDA-approved drugs. This is often studied using aging clocks, which measure biological age by evaluating different aging processes. Evaluate the effects of COVID-19 on the sector.

Drugs 363

Drugs Regulation Clinical Trials Clinical Trials 363

Pharmaceutical Technology

JANUARY 6, 2023

Last year, Novartis began with a win in January, as the US Court of Appeals affirmed the validity of Gilenya’s patent, allowing the company to sue a competitor generics company for filing for FDA approval for its Gilenya generic. By GlobalData. Gilenya is an oral medication for multiple sclerosis. United Kingdom. United States.

Doctors 242

Doctors Doctor Drugs Sales 242

Pharmaceutical Technology

DECEMBER 4, 2022

There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January. Broadly speaking, price is the determining factor on the US healthcare market, says Jakub Hlávka, PhD, research assistant professor of health policy and management at the University of South California, Los Angeles.

Marketing 262

Marketing Pharmacy Production Branding 262

Pharmaceutical Technology

MARCH 16, 2023

Dr Lisa Campo-Engelstein, a bioethicist, predicts that these factors and subsequent restrictions on statewide healthcare coverage will heavily restrict patient access to gender-affirming care. Campo-Engelstein is the director of the Institute for Bioethics & Health Humanities at the University of Texas Medical Branch, Galveston.

Drugs 360

Drugs Hormones Trials FDA Approval 360